
Deanna L. Pratt
Examiner (ID: 3454, Phone: (571)272-7649 , Office: P/2911 )
| Most Active Art Unit | 2911 |
| Art Unit(s) | 2931, 2911 |
| Total Applications | 2897 |
| Issued Applications | 2827 |
| Pending Applications | 10 |
| Abandoned Applications | 66 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10919753
[patent_doc_number] => 20140322771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'Lipid Production'
[patent_app_type] => utility
[patent_app_number] => 13/992444
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24796
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992444
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992444 | Lipid Production | Dec 8, 2011 | Abandoned |
Array
(
[id] => 8323568
[patent_doc_number] => 20120195976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION'
[patent_app_type] => utility
[patent_app_number] => 13/315791
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 27075
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13315791
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/315791 | METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION | Dec 8, 2011 | Abandoned |
Array
(
[id] => 9191493
[patent_doc_number] => 20130330808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'NOVEL PROCESS FOR THE PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR'
[patent_app_type] => utility
[patent_app_number] => 13/885002
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4743
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885002
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/885002 | Process for the purification of tissue plasminogen activator | Nov 14, 2011 | Issued |
Array
(
[id] => 7817965
[patent_doc_number] => 20120064585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'Increased Heterologous Fe-S Enzyme Activity in Yeast'
[patent_app_type] => utility
[patent_app_number] => 13/296944
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 46363
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064585.pdf
[firstpage_image] =>[orig_patent_app_number] => 13296944
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/296944 | Recombinant yeast host cell with Fe-S cluster proteins and methods of using thereof | Nov 14, 2011 | Issued |
Array
(
[id] => 8172369
[patent_doc_number] => 20120107888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'MODULATION OF FERMENTATION PRODUCTS THROUGH VITAMIN SUPPLEMENTATION'
[patent_app_type] => utility
[patent_app_number] => 13/289568
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 69736
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20120107888.pdf
[firstpage_image] =>[orig_patent_app_number] => 13289568
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/289568 | MODULATION OF FERMENTATION PRODUCTS THROUGH VITAMIN SUPPLEMENTATION | Nov 3, 2011 | Abandoned |
Array
(
[id] => 7779013
[patent_doc_number] => 20120041232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR 3-HYDROXYPROPIONATE BIO-PRODUCTION FROM BIOMASS'
[patent_app_type] => utility
[patent_app_number] => 13/284337
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20238
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041232.pdf
[firstpage_image] =>[orig_patent_app_number] => 13284337
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/284337 | Compositions and methods for 3-hydroxypropionate bio-production from biomass | Oct 27, 2011 | Issued |
Array
(
[id] => 10516197
[patent_doc_number] => 09243237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Method for mass production of factor VII/VIIA'
[patent_app_type] => utility
[patent_app_number] => 13/881974
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6946
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881974
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881974 | Method for mass production of factor VII/VIIA | Oct 25, 2011 | Issued |
Array
(
[id] => 10587950
[patent_doc_number] => 09309553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus'
[patent_app_type] => utility
[patent_app_number] => 13/272949
[patent_app_country] => US
[patent_app_date] => 2011-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24404
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13272949
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/272949 | Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus | Oct 12, 2011 | Issued |
Array
(
[id] => 9345054
[patent_doc_number] => 08664202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-04
[patent_title] => 'Cross-linked bioactive hydrogel matrices'
[patent_app_type] => utility
[patent_app_number] => 13/252500
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 11759
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252500 | Cross-linked bioactive hydrogel matrices | Oct 3, 2011 | Issued |
Array
(
[id] => 10837768
[patent_doc_number] => 08865441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Efficient cell-free hydrogen production'
[patent_app_type] => utility
[patent_app_number] => 13/246542
[patent_app_country] => US
[patent_app_date] => 2011-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12055
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13246542
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/246542 | Efficient cell-free hydrogen production | Sep 26, 2011 | Issued |
Array
(
[id] => 7710170
[patent_doc_number] => 20120003205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION OF LIVER DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/234847
[patent_app_country] => US
[patent_app_date] => 2011-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8263
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13234847
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/234847 | Pharmaceutical composition containing arazyme for the prevention of liver dysfunction | Sep 15, 2011 | Issued |
Array
(
[id] => 7720300
[patent_doc_number] => 20120009635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'Metabolically Engineered Bacterial Strains Having Non-Functional Endogenous Gluconate Transporters'
[patent_app_type] => utility
[patent_app_number] => 13/228833
[patent_app_country] => US
[patent_app_date] => 2011-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17154
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20120009635.pdf
[firstpage_image] =>[orig_patent_app_number] => 13228833
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/228833 | Metabolically Engineered Bacterial Strains Having Non-Functional Endogenous Gluconate Transporters | Sep 8, 2011 | Abandoned |
Array
(
[id] => 7710169
[patent_doc_number] => 20120003204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANDER'
[patent_app_type] => utility
[patent_app_number] => 13/225317
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9685
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13225317
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/225317 | Composition containing arazyme for the prevention and treatment of cancer | Sep 1, 2011 | Issued |
Array
(
[id] => 7808194
[patent_doc_number] => 20120059148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'NON-NATURALLY OCCURRING LIPOPROTEIN PARTICLE'
[patent_app_type] => utility
[patent_app_number] => 13/214862
[patent_app_country] => US
[patent_app_date] => 2011-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12984
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20120059148.pdf
[firstpage_image] =>[orig_patent_app_number] => 13214862
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/214862 | NON-NATURALLY OCCURRING LIPOPROTEIN PARTICLE | Aug 21, 2011 | Abandoned |
Array
(
[id] => 8430858
[patent_doc_number] => 20120252732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'ALBUMIN FUSION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/212879
[patent_app_country] => US
[patent_app_date] => 2011-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 115829
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212879
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/212879 | ALBUMIN FUSION PROTEINS | Aug 17, 2011 | Abandoned |
Array
(
[id] => 17156443
[patent_doc_number] => 20210317494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Liquor And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 13/814912
[patent_app_country] => US
[patent_app_date] => 2011-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814912
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/814912 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Liquor And Uses Thereof | Aug 4, 2011 | Abandoned |
Array
(
[id] => 10857775
[patent_doc_number] => 08883970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Alpha-amylase variants'
[patent_app_type] => utility
[patent_app_number] => 13/187014
[patent_app_country] => US
[patent_app_date] => 2011-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 86772
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187014
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/187014 | Alpha-amylase variants | Jul 19, 2011 | Issued |
Array
(
[id] => 9166503
[patent_doc_number] => 08592180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Botryoccocus braunii triterpene synthase proteins and nucleic acid molecules, and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 13/186185
[patent_app_country] => US
[patent_app_date] => 2011-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 14017
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13186185
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/186185 | Botryoccocus braunii triterpene synthase proteins and nucleic acid molecules, and methods for their use | Jul 18, 2011 | Issued |
Array
(
[id] => 9496724
[patent_doc_number] => 08735540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Peptides with sequentially arranged streptavidin binding modules'
[patent_app_type] => utility
[patent_app_number] => 13/185070
[patent_app_country] => US
[patent_app_date] => 2011-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 10980
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13185070
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/185070 | Peptides with sequentially arranged streptavidin binding modules | Jul 17, 2011 | Issued |
Array
(
[id] => 9937154
[patent_doc_number] => 08986960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Microorganisms with extended substrate utilization range'
[patent_app_type] => utility
[patent_app_number] => 13/183638
[patent_app_country] => US
[patent_app_date] => 2011-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 22273
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183638
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/183638 | Microorganisms with extended substrate utilization range | Jul 14, 2011 | Issued |